The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
Abstract Background In 2019, Chinese government launched a nationwide volume-based drug procurement aiming at reducing drug prices and saving drug costs through economies of scale, which aroused widespread attention. The first round of the policy pilot was implemented in 4 municipalities and 7 sub-p...
Enregistré dans:
Auteurs principaux: | Ying Yang, Ruiwen Tong, Shicheng Yin, Lining Mao, Luxinyi Xu, Siyu Hao, Zongfu Mao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c35a4f2eaefa4e73b2980ad46aa3d79a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Assessment of Innovations in Procurement Practices
par: Tatyana Vladimirovna Kasyanova
Publié: (2018) -
Understanding the Determinants and Specifics of Pre-Commercial Procurement
par: Delina,Radoslav, et autres
Publié: (2021) -
CERIMETRIC DETERMINATION OF FOUR ANTIHYPERTENSIVE DRUGS IN PHARMACEUTICAL PREPARATIONS
par: EL-DIDAMONY,A.M, et autres
Publié: (2011) -
Comparative analysis of classifications of public procurement
par: Yuriy Hruzky
Publié: (2021) -
Public procurement in Ukraine: analysis of advantages and disadvantages
par: O.A., et autres
Publié: (2021)